choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Emtricitabine

Emtricitabine Newsletter
  • FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag 20 Jun 2025 12:01 GMT

    … U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc … PURPOSE 2 trials remained HIV negative. The first PrEP medication, which … once-daily oral Truvada (emtricitabine 200mg and tenofovir disoproxil … . In the PURPOSE 2 trial, there were two HIV …

  • Gilead Sciences' Yeztugo receives nod; the first and only US FDA─approved HIV prevention option offering 6 months of protection 20 Jun 2025 04:44 GMT

    … once-daily oral Truvada (emtricitabine 200mg and tenofovir disoproxil fumarate … . In the PURPOSE 2 trial (NCT04925752), there were two … trials were published in The New England Journal of Medicine … countries for the treatment of multi-drug-resistant HIV in …

  • Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision 20 Jun 2025 01:44 GMT

    … and PURPOSE 2 (NCT04925752) trials, in which the therapy … MD, distinguished professor of medicine in the division of … and once-daily oral emtricitabine and tenofovir disoproxil fumarate … reduction associated with lenacapavir treatment when compared to …

  • Gilead's twice-yearly PrEP drug is cleared by FDA 18 Jun 2025 23:24 GMT

    … 2, and in both trials the drug was significantly better at … daily oral PrEP product Truvada (emtricitabine and tenofovir disoproxil fumarate). … there is a pool of treatment-naïve people who have … possible brakes on uptake like Medicaid cuts, saying: "We …

  • FDA Approves First Twice-Yearly Injectable PrEP for HIV Prevention 19 Jun 2025 22:04 GMT

    … clinical trials The FDA approval of Gilead’s New Drug Applications … once-daily oral Truvada® (emtricitabine 200mg and tenofovir disoproxil … of Medicine and, based in part on the trial results, … ’s HIV prevention and treatment research program. Lenacapavir is …

  • New HIV Prevention Drug Approved—Now Let’s Remove the Final Barrier 19 Jun 2025 21:47 GMT

    … FDA already permits patients with treatment-resistant HIV to access the drug … (emtricitabine/​tenofovir) sells for a dollar per pill. … costs of visiting a doctor to obtain a prescription … options for purchasing OTC medications, including online services, …

  • Gilead Sciences’ twice-yearly HIV PrEP drug Yeztugo granted FDA approval 19 Jun 2025 11:55 GMT

    … the late-stage PURPOSE 1 trial, which randomised over 5 … s once-daily oral PrEP drugs, Descovy (emtricitabine/tenofovir alafenamide) … Yeztugo group. In both trials, Yeztugo also demonstrated superiority … epidemic. “This is a medicine that only needs to be …

  • Injectable HIV Prevention Drug Gets FDA Nod 19 Jun 2025 08:34 GMT

    … US Food and Drug Administration’s (FDA’s) approval of … oral combination therapy of emtricitabine and tenofovir disoproxil fumarate … Advancing Access medication assistance program will provide the drug at no … Therapy Designation by the FDA in October 2024 and …

  • FDA Approves Twice-Yearly Lenacapavir for HIV Prevention 19 Jun 2025 03:49 GMT

    … the Food and Drug Administration (FDA) approved twice-yearly … combination regimen for treatment-experienced people with … fumarate/emtricitabine). Gilead’s Descovy pill (tenofovir disoproxil … will work with pharmaceutical manufacturers to offer …

  • FDA Approves Lenacapavir for Prevention of HIV 19 Jun 2025 01:42 GMT

    … and PURPOSE 2 (NCT04925752) trials, in which the therapy met … MD, distinguished professor of medicine in the Division of … multicenter, randomized phase 3 trial evaluating the safety and … and once-daily oral emtricitabine and tenofovir disoproxil fumarate …

Satisfied with the content?

Continue to create your account.